Brian L. Koopman is the current CEO and Principal Financial Officer at Utah Medical Products, Inc. (UTMD), a company he joined in 2006. He has been steering the financial strategy of UTMD since his appointment as Principal Financial Officer in...
Brian L. Koopman is the current CEO and Principal Financial Officer at Utah Medical Products, Inc. (UTMD), a company he joined in 2006. He has been steering the financial strategy of UTMD since his appointment as Principal Financial Officer in 2018. Born in 1983, Brian has a background in finance, emphasizing how he blends technical expertise with leadership in a competitive market. What’s interesting is that he has seen his compensation grow over the years, with a total compensation of $165,319 in 2023, including a salary and stock options, but no bonuses awarded. Brian's strategy focuses on aligning performance with company goals, which is key in the medical products industry. He also has a track record of significant stock option grants, illustrating the trust placed in him by the company, along with a hands-on approach to managing finances. Notably, Brian has engaged in consistent insider trading activities, showing his commitment and financial stake in the company’s success, with trades amounting to over $400,000 in value since 2019. He did not exercise any options in 2023, but he has options vesting over several years, reflecting a long-term outlook for both himself and shareholders. Brian’s role in UTMD has positioned him as a crucial player in the medical technology field, and his financial decisions impact the company’s future and success.